RESUMEN
BACKGROUND: The constrained posterior-stabilized (CPS) implant for use in total knee arthroplasty (TKA) has a constraint level midway between that of a posterior-stabilized implant and a valgus-varus-constrained implant; there is currently no consensus on the surgical indications for use of this degree of constraint. We present our experience using this implant at our centre. METHODS: We reviewed the charts of patients who received a CPS polyethylene insert during TKA in our centre between January 2016 and April 2020. We collected patient demographic characteristics, surgical indications, pre- and postoperative radiographs, and complications. RESULTS: A total of 85 patients (74 females and 11 males with a mean age of 73 yr [standard deviation 9.4 yr, range 36-88 yr]) (85 knees) received a CPS insert over the study period. Of the 85 cases, 80 (94%) were primary TKA and 5 (6%) were revision TKA. The most common indications for primary CPS use were severe valgus deformity with medial soft-tissue laxity (29 patients [34%]), medial soft-tissue laxity without substantial deformity (27 [32%]) and severe varus deformity with lateral soft-tissue laxity (13 [15%]). The indications for the 5 patients who underwent revision TKA were medial laxity (4 patients) and an iatrogenic lateral condyle fracture (1 patient). Four patients had postoperative complications. The 30-day return to hospital rate was 2.3% (owing to infection and hematoma). A single patient required revision surgery for periprosthetic joint infection. CONCLUSION: We found excellent short-term survivorship of the CPS polyethylene insert when used for a spectrum of coronal plane ligamentous imbalances with or without pre-operative coronal plane deformities. Long-term follow-up of these cases will be important to identify adverse outcomes such as loosening or polyethylene-related problems.
Asunto(s)
Artroplastia de Reemplazo de Rodilla , Prótesis de la Rodilla , Femenino , Masculino , Humanos , Anciano , Reoperación , Artroplastia de Reemplazo de Rodilla/efectos adversos , Prótesis de la Rodilla/efectos adversos , Polietileno , Medición de RiesgoRESUMEN
INTRODUCTION: One of the most important challenges faced by orthopedic surgeons is periprosthetic joint infection (PJI). PJI is a common cause for total joint arthroplasty failure with an incidence of 0.3-1.9%. PJI can be devastating for the patient and extremely costly for the healthcare system. There is concern that a major cause of PJI is intra-operative colonization and recent studies have shown a decrease in PJI with the use of dilute povidone-iodine (Betadine®, Avrio Health L.P, Stamford, CT) irrigation prior to wound closure. This study presents our experience with the use of dilute Betadine® irrigation prior to wound closure and its effect on our post-operative hip and knee arthroplasty acute infection rate. MATERIALS AND METHODS: Retrospective chart review performed at our hospital looking at PJI amongst patients who underwent primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) between 2013 and 2017 comparing different irrigation methods (n = 3232). The study group (n = 1207) underwent irrigation prior to wound closure with dilute Betadine for 3 min and the control group (n = 1511) underwent irrigation using normal saline (NS). RESULTS: Using a logistic regression model where the following variables were adjusted for; ASA, age, sex, foley insertion, surgical duration and diabetes mellitus status a statistical significant reduction was seen in any infection (OR 0.45 [0.22; 0.89], p value < 0.05) and SSI (OR 0.30 [0.13; 0.70], p value 0.01) with the Betadine group. No significant reduction was seen with deep infections with the Betadine group compared to the NS group. CONCLUSION: PJI is a devastating complication following total joint arthroplasty and we found Betadine compared to NS irrigation provides an inexpensive and simple method to lower any PJI and more specifically SSI in THA and TKA. LEVEL OF EVIDENCE: III.
Asunto(s)
Artritis Infecciosa , Artroplastia de Reemplazo de Cadera , Artroplastia de Reemplazo de Rodilla , Infecciones Relacionadas con Prótesis , Humanos , Povidona Yodada/uso terapéutico , Artroplastia de Reemplazo de Rodilla/efectos adversos , Estudios Retrospectivos , Infecciones Relacionadas con Prótesis/etiología , Infecciones Relacionadas con Prótesis/prevención & control , Infecciones Relacionadas con Prótesis/epidemiología , Artroplastia de Reemplazo de Cadera/efectos adversos , Artritis Infecciosa/complicacionesRESUMEN
BACKGROUND: The long-term survivorship and functional outcomes of the mobile-bearing (MB) compared to the fixed-bearing (FB) unicompartmental knee arthroplasty (UKA) implant design remain a topic of debate. The aim of the current study was to compare the survivorship and functional outcomes of MB and FB UKA at a minimum 10-year follow-up. METHODS: We retrospectively reviewed 106 consecutive medial UKAs (89 patients) from our institution with a minimum 10-year follow-up. The 38 MB and 68 FB knees had follow-up of 14.2 years (12.9-15.5) and 11.5 years (10.2-15.1), respectively. Validated patient-reported outcomes and radiographs were evaluated as were etiology, timing, and complexity of revision. Kaplan-Meier 10-year survival was calculated with revision to total knee arthroplasty as the end point. RESULTS: The 10-year survival was 82.9% (95% confidence interval [CI] 65.8-91.9) for MB and 90.9% (95% CI 79.4-96.2) for FB UKA (P = .102), and 88.0% (95% CI 79.3-93.2) for the entire cohort. Patient outcomes were similar between groups, as were timing and etiologies for revision to total knee arthroplasty. One-third of revisions required either stems or tibial augments, and of these, all were of MB design. CONCLUSION: Survival and functional outcomes were similar between MB and FB designs. One-third of revisions required either stems or augments, all were of MB design.
Asunto(s)
Artroplastia de Reemplazo de Rodilla/instrumentación , Prótesis de la Rodilla/estadística & datos numéricos , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Articulación de la Rodilla/cirugía , Masculino , Persona de Mediana Edad , Osteoartritis de la Rodilla/cirugía , Medición de Resultados Informados por el Paciente , Diseño de Prótesis , Falla de Prótesis , Radiografía , Estudios Retrospectivos , Tibia/cirugía , Resultado del TratamientoRESUMEN
BACKGROUND: Shorter femoral stems have been increasingly used in total hip arthroplasty. However, there are few clinical studies evaluating the outcomes of these stems and comparing them to their regular-sized counterparts. METHODS: Our study provides radiologic and functional outcomes at 5-year mean follow-up of 131 cementless Tri-Lock Bone Preservation Stems, a short tapered stem with a proximal porous coating. RESULTS: Stem-related complications were low with one revision for stem aseptic loosening. Kaplan-Meier analysis estimated 99.2% stem survival rate at 5 years, comparable to conventional length Tri-Lock stems (99.8% at 8.9 years). CONCLUSION: This study demonstrates that the Tri-Lock Bone Preservation Stem can provide successful outcomes at 5-year follow-up. Further studies are required to determine the long-term outcome of these implants in patients with poor bone stock.
Asunto(s)
Artroplastia de Reemplazo de Cadera/instrumentación , Prótesis de Cadera/estadística & datos numéricos , Adulto , Anciano , Anciano de 80 o más Años , Huesos/cirugía , Femenino , Fémur/cirugía , Estudios de Seguimiento , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Porosidad , Diseño de Prótesis , Reoperación , Resultado del TratamientoRESUMEN
BACKGROUND: Nontraumatic osteonecrosis of the femoral head (ONFH) is a progressive disease in young adults producing substantial morbidity and frequently resulting in total hip arthroplasty. Although hip-preserving surgical procedures represent the current mainstay of treatment for early disease, medical therapies targeting specific pathways in the ONFH pathogenesis could help prevent disease progression while producing less morbidity. Acetylsalicylic acid (ASA) is a promising alternative to other therapies for ONFH owing to its anti-inflammatory and antithrombotic mechanisms of action and its relatively benign side effect profile. METHODS: We followed a prospective cohort of 10 patients (12 hips) with precollapse ONFH who were given ASA to prevent disease progression. Their outcomes were compared with those of a historic control group taken from the literature. RESULTS: Progression occurred in 1 of 12 (8%) patients taking ASA compared with 30 of 45 (66.6%) controls (p = 0.002) at a mean follow-up of 3.7 years. Patients taking ASA also tended to exhibit decreased femoral head involvement at the end of therapy. CONCLUSION: This hypothesis-generating study leads us to believe that ASA may be a simple and effective treatment option for delaying disease progression in patients with early-stage ONFH.
CONTEXTE: L'ostéonécrose non traumatique de la tête fémorale (ONTF) est une maladie progressive qui affecte les adultes jeunes, s'accompagne d'une morbidité substantielle et mène souvent à une arthroplastie totale de la hanche. Même si les interventions chirurgicales visant à préserver la hanche représentent la pierre angulaire actuelle du traitement pour la maladie au stade précoce, les traitements médicamenteux qui ciblent les voies spécifiques de la pathogenèse de l'ONTF pourraient contribuer à prévenir la progression de la maladie tout en atténuant la morbidité. L'acide acétylsalicylique (AAS) est une solution de rechange prometteuse aux autres traitements indiqués pour l'ONTF en raison de ses propriétés anti-inflammatoires et antithrombotiques et de son profil d'innocuité relativement bénin. MÉTHODES: Nous avons suivi une cohorte prospective de 10 patients (12 hanches) présentant une ONTF au stade précollapsus qui ont reçu de l'AAS pour prévenir la progression de la maladie. Leurs résultats ont été comparés à ceux d'un groupe témoin historique de patients décrits dans la littérature. RÉSULTANTS: La progression a affecté 1 patient sur 12 (8 %) traités par AAS, contre 30 témoins sur 45 (66,6 %) (p = 0,002) après un suivi moyen de 3,7 ans. Les patients sous AAS avaient tendance à présenter une atteinte moins prononcée de la tête fémorale à la fin du traitement. CONCLUSION: Cette étude exploratoire nous amène à croire que l'AAS pourrait être une option thérapeutique simple et efficace pour retarder la progression de la maladie chez les patients au stade précoce d'une ONTF.
Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Aspirina/uso terapéutico , Necrosis de la Cabeza Femoral/tratamiento farmacológico , Administración Oral , Adulto , Anciano , Progresión de la Enfermedad , Esquema de Medicación , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Estudios Prospectivos , Resultado del TratamientoRESUMEN
PURPOSE: The aim of this study is to determine the validity of consumer grade step counter devices during the early recovery period after knee replacement surgery. METHODS: Twenty-three participants wore a Fitbit Charge or Apple Watch Series 4 smart watch and performed a walking test along a 50-metre hallway. There were 9 males and 14 females included in the study with an average age of 68.5 years and BMI of 32. Each patient wore both the Fitbit Charge and Apple Watch while completing the walking test and an observer counted the ground truth value using a thumb-push tally counter. This test was repeated pre-operatively with no gait aid, immediately post operatively with a walker, at 6 weeks follow up with a cane and at 6 months with no gait aid. Bland-Altman plots were performed for all walking tests to compare the agreement between measurement techniques. RESULTS: Mean overall agreement of step count for pre-operative and at 6 months for subjects walking without gait aids was excellent for both the Apple Watch vs. actual and Fitbit vs. actual with bias values ranging from - 0.87 to 1.36 with limits of agreement (LOA) ranging between - 10.82 and 15.91. While using a walker both devices showed extremely little agreement with the actual step count with bias values between 22.5 and 24.37 with LOA between 11.7 and 33.3. At 6 weeks post-op while using a cane, both the Apple Watch and Fitbit devices had a range of bias values between - 2.8 and 5.73 with LOA between - 13.51 and 24.97. CONCLUSIONS: These devices show poor validity in the early post operative setting, especially with the use of gait aids, and therefore results should be interpreted with caution.
Asunto(s)
Artroplastia de Reemplazo de Rodilla , Humanos , Femenino , Masculino , Anciano , Artroplastia de Reemplazo de Rodilla/instrumentación , Persona de Mediana Edad , Marcha/fisiología , Bastones , Caminata/fisiología , Reproducibilidad de los Resultados , Andadores , Monitores de Ejercicio , Anciano de 80 o más AñosRESUMEN
Sickle cell disease (SCD) is an autosomal recessive disorder that is characterized by abnormal "sickle-shaped" erythrocytes. Because of their shape, these erythrocytes are more likely to become trapped in small slow-flowing vessels, leading to vaso-occlusion. Because this commonly happens in the bones, patients with SCD are at an increased risk for orthopaedic manifestations such as osteomyelitis, septic joint, or osteonecrosis. Osteomyelitis is a serious and potentially disabling condition but can be difficult to differentiate from benign conditions of SCD, such as vaso-occlusive crisis. Diagnosis of osteomyelitis requires careful evaluation of the clinical presentation, laboratory testing, and imaging. Treatment of osteomyelitis in patients with SCD may be medical or surgical, but considerations in antibiotic selection and management preoperatively and postoperatively must be taken to ensure optimal outcomes.
Asunto(s)
Anemia de Células Falciformes , Artritis Infecciosa , Osteomielitis , Osteonecrosis , Enfermedades Vasculares , Anemia de Células Falciformes/complicaciones , Humanos , Osteomielitis/diagnóstico , Osteonecrosis/diagnósticoRESUMEN
Two-stage exchange arthroplasty remains the treatment of choice for chronic periprosthetic joint infections. This retrospective study conducted between 2009 and 2015 examined the diagnostic value of biomarkers for residual infection between stages. The biomarkers evaluated included C-reactive protein prior to reimplantation, preimplantation synovial fluid white blood cell count and percent neutrophils, and the intraoperative histologic synovial white blood cell count per high-power field (×400) on permanent sections. Residual infection was defined as either positive cultures (more than 1) at second stage, any further surgery (eg, amputation, arthrodesis, or another 2-stage revision), or the need for infection suppression with antibiotics. Sensitivity, specificity, positive and negative predictive values, and likelihood ratios were calculated accordingly. A total of 182 two-stage exchange operations that included 109 (59.9%) prosthetic hips and 73 (40.1%) prosthetic knees met the inclusion criteria. Residual infection was present in 38 (20.9%) of the procedures. The area under the curve-receiver operating characteristic values were 0.677 for C-reactive protein (P=.002), 0.506 for aspiration white blood cell count (P=.944), 0.623 for aspiration percent neutrophils (P=.200), and 0.524 for white blood cell count per high-power field (P=.801). Positive and negative predictive values were poor and ranged between 26% and 57% and 78% and 85%, respectively. Analyses using specific combinations of biomarkers did not significantly improve predictive values. This study showed that classic markers perform poorly in identifying residual infection prior to second-stage revision. Further research is necessary to evaluate the diagnostic utility of other, more recently introduced biomarkers to determine whether infection has been eradicated between stages. [Orthopedics. 2019; 42(1):34-40.].
Asunto(s)
Proteína C-Reactiva/análisis , Recuento de Leucocitos , Neutrófilos/metabolismo , Infecciones Relacionadas con Prótesis/diagnóstico , Líquido Sinovial/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Artroplastia de Reemplazo de Cadera/efectos adversos , Artroplastia de Reemplazo de Rodilla/efectos adversos , Biomarcadores/metabolismo , Femenino , Prótesis de Cadera/efectos adversos , Humanos , Prótesis de la Rodilla/efectos adversos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Infecciones Relacionadas con Prótesis/cirugía , Reoperación , Estudios Retrospectivos , Sensibilidad y EspecificidadRESUMEN
Femoral neck fractures account for nearly half of all hip fractures with the vast majority occurring in elderly patients after simple falls. Currently there may be sufficient evidence to support the routine use of hip replacement surgery for low demand elderly patients in all but non-displaced and valgus impacted femoral neck fractures. However, for the physiologically young patients, preservation of the natural hip anatomy and mechanics is a priority in management because of their high functional demands. The biomechanical challenges of femoral neck fixation and the vulnerability of the femoral head blood supply lead to a high incidence of non-union and osteonecrosis of the femoral head after internal fixation of displaced femoral neck fractures. Anatomic reduction and stable internal fixation are essentials in achieving the goals of treatment in this young patient population. Furthermore, other management variables such as surgical timing, the role of capsulotomy and the choice of implant for fixation remain controversial. This review will focus both on the demographics and injury profile of young patients with femoral neck fractures and the current evidence behind the surgical management of these injuries as well as their major secondary complications.